Synektik Spólka Akcyjna Valuation
Is SNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SNT (PLN151.5) is trading above our estimate of fair value (PLN123.87)
Significantly Below Fair Value: SNT is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SNT?
Other financial metrics that can be useful for relative valuation.
What is SNT's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | zł1.29b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2x |
Enterprise Value/EBITDA | 11.3x |
PEG Ratio | 4.5x |
Price to Earnings Ratio vs Peers
How does SNT's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 37.2x | ||
VOX Voxel | 15.4x | 12.2% | zł985.1m |
EMC EMC Instytut Medyczny | 39.7x | n/a | zł474.7m |
6841 Ever Fortune.AI | 62.7x | n/a | NT$8.6b |
NEU NEUCA | 31x | 25.7% | zł3.9b |
SNT Synektik Spólka Akcyjna | 19x | 4.3% | zł1.3b |
Price-To-Earnings vs Peers: SNT is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (37.2x).
Price to Earnings Ratio vs Industry
How does SNT's PE Ratio compare vs other companies in the European Healthcare Services Industry?
Price-To-Earnings vs Industry: SNT is good value based on its Price-To-Earnings Ratio (19x) compared to the European Healthcare Services industry average (21.3x).
Price to Earnings Ratio vs Fair Ratio
What is SNT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 19x |
Fair PE Ratio | 19.1x |
Price-To-Earnings vs Fair Ratio: SNT is good value based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (19.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | zł151.50 | zł119.05 -21.4% | 16.0% | zł138.10 | zł100.00 | n/a | 2 |
Mar ’25 | zł131.50 | zł119.05 -9.5% | 16.0% | zł138.10 | zł100.00 | n/a | 2 |
Feb ’25 | zł90.00 | zł104.85 +16.5% | 4.6% | zł109.70 | zł100.00 | n/a | 2 |
Jan ’25 | zł86.00 | zł104.85 +21.9% | 4.6% | zł109.70 | zł100.00 | n/a | 2 |
Dec ’24 | zł80.40 | zł97.75 +21.6% | 2.3% | zł100.00 | zł95.50 | n/a | 2 |
Nov ’24 | zł62.80 | zł91.25 +45.3% | 4.7% | zł95.50 | zł87.00 | n/a | 2 |
Oct ’24 | zł60.60 | zł91.25 +50.6% | 4.7% | zł95.50 | zł87.00 | n/a | 2 |
Sep ’24 | zł72.20 | zł91.25 +26.4% | 4.7% | zł95.50 | zł87.00 | n/a | 2 |
Analyst Forecast: Target price is lower than the current share price.